Articles

Your Daily News Roundup We’re all in this together! Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place.  Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better cope with …

One of the most common chronic disease in children and adolescents is type 1 diabetes;  studies reveal that more than 40 million individuals are affected worldwide by the condition. In patients with type 1 diabetes, the pancreas no longer produces insulin because the body’s immune system attacks its beta cells for reasons still unknown. Today’s …

Your Daily News Roundup We’re all in this together!  Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place.  Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better cope with …

David Walton, CEO of T1D Exchange, sat down this week with Scott Benner, host of the Juicebox Podcast, to talk about their respective history with type 1 diabetes. The conversation covered a wide range of topics: Scott and Dave discussed their personal relationships with T1D, experiences in the industry, and strategies for dealing with the disease. …

The COVID-19 pandemic has put immense pressure on both individuals with T1D, and the organizations who provide them with vital supplies and medications. While there’s no doubt that people with T1D face a more uncertain and risk-filled future as we navigate quarantine and social distancing, there have been some promising steps from several sides that have …

The ongoing outbreak of the novel respiratory disease COVID-19 has become a significant threat to global health and individuals with pre-existing medical conditions. To gain a deeper understanding of how the coronavirus is affecting people with type 1 diabetes, T1D Exchange is leading a first-of-its-kind COVID-19 research surveillance study in partnership with more than 50 …

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

t1D exchange is launching a surveillance study of patients with COVID-19 and diabetes

T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). The results of the study will be used to better understand the etiology and potential outcomes in COVID-19 patients and inform future clinical quality improvement activities to better respond to the global pandemic.

Lately, we are inundated with negative reports and information surrounding the Coronavirus outbreak. Fortunately, there is some good news for people with type 1 diabetes. Eli Lilly announced that beginning April 6, 2020, and for $35.00 dollars a month regardless of having a health insurance plan or not having health insurance at all, people with …

The last few weeks have been a harrowing experience for thousands of people around the world. The public health crisis caused by the novel coronavirus COVID-19 threatens to overwhelm doctors and hospitals with an alarming number of deaths and infections.